TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced further progress on Thursday in its Phase 1a clinical trial of TTX-MC138 in patients with metastatic cancer. To date, 13 patients have received at ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. SIOUX FALLS, Iowa—Sencore will introduce a comprehensive OTT workflow package and enhancements to ...
The University of Texas MD Anderson Cancer Center and TransCode Therapeutics, Inc. today announced a strategic alliance to advance TransCode's pipeline of RNA-targeted oncology therapeutic and ...
(RTTNews) - TransCode Therapeutics, Inc. (RNAZ), a clinical-stage oncology company focused on RNA therapeutics, announced on Wednesday that it has entered into a securities purchase agreement to raise ...
In this test, we dropped the finished clip into a watch folder or directly into the compression application, bypassing the companion NLE. One parameter yielded one output file. Given the limitation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback